NCT Number: NCT01215656
Effect of a Follow on Formula With Lactobacillus Fermentum on the Incidence of Infections
The objective of the study is to evaluate the effects of a follow on formula containing the human milk probiotic Lactobacillus fermentum on the incidence of infection in 6 months old infants.
Looking for future studies?
Notify MeKey information
Conditions
Age range
6 month–7 month
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2 / Phase 3
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 6 months old children born at term
- written consent from parents
Exclusion criteria
- frequent gastrointestinal disorders (frequent diarrhoeas, constipation episodes, gastroesophageal reflux)
- gastrointestinal surgery
- cow's milk protein allergy
- metabolic diseases (diabetes or lactose intolerance)
- immune deficiency
- antibiotic treatment during the trial and/or recent (within the preceding 3 weeks)
Treatment and study plan
Follow on formula without probiotics
Dietary SupplementPrimary outcomes
-
Incidence of infectious diseases
Sponsors and collaborators
Lead sponsor
Puleva Biotech
Industry
Registry information
Important dates
- Study start
- 2008
- Primary completion
- 2010
- First posted
- Oct 6, 2010
- Registry last updated
- Oct 7, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients
NCT07308457
Incidence of Infectious Diseases, Infections
Szczecin, West Pomeranian Voivodeship, Poland
View Trial Details